Junnan Xu

Chinese PLA General Hospital

Papers

1

Total Citations

15

H-Index

1

About

Dr. Junnan Xu is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for renal cell carcinoma, with a particular focus on optimizing outcomes in robotic partial nephrectomy. His major contributions lie in comparative effectiveness research, where he has systematically evaluated the transperitoneal and retroperitoneal approaches for complex kidney tumors. In his highly cited 2022 study, "Comparison of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Patients With Complete Upper Pole Renal Tumors," Dr. Xu provided critical evidence guiding surgical decision-making for challenging upper pole masses. This work, which has garnered 15 citations, offers urologists a data-driven framework for selecting the optimal surgical corridor to maximize oncologic control while minimizing complications. Dr. Xu’s research is distinguished by its rigorous methodology and direct clinical applicability, helping to refine the standard of care in nephron-sparing surgery. His ongoing investigations continue to shape best practices in robotic urologic oncology, making him a respected voice in the field and a valuable resource for surgeons and trainees seeking to master these advanced techniques.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Patients With Complete Upper Pole Renal Tumors
15 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Chinese PLA General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago